FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074962 [Registered on: 08/10/2024] Trial Registered Prospectively
Last Modified On: 27/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Benefit of Virtual Reality in rehabilitation of patients with chronic vertigo/giddiness 
Scientific Title of Study   Evaluation of Virtual Reality Assisted Therapy as an Adjunct to Conventional Vestibular Rehabilitation Therapy for Chronic Vestibular Hypofunction: A Randomized Controlled Trial 
Trial Acronym  VIRAT (virtual reality assisted therapy) 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Garima Upreti 
Designation  Assistant Professor, Otorhinolaryngology 
Affiliation  All India Institute of Medical Sciences-Rajkot 
Address  Department of Otorhinolaryngology, All India Institute of Medical Sciences, Rajkot, Gujarat, India

Rajkot
GUJARAT
360006
India 
Phone  9871252109  
Fax    
Email  grmprt@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Garima Upreti 
Designation  Assistant Professor, Otorhinolaryngology 
Affiliation  All India Institute of Medical Sciences-Rajkot 
Address  Department of Otorhinolaryngology, All India Institute of Medical Sciences, Rajkot, Gujarat, India

Rajkot
GUJARAT
360006
India 
Phone  9871252109  
Fax    
Email  grmprt@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Siddhi Patil 
Designation  Junior Resident (Academic), Otorhinolaryngology 
Affiliation  All India Institute of Medical Sciences-Rajkot 
Address  Department of Otorhinolaryngology, All India Institute of Medical Sciences, Rajkot, Gujarat, India

Rajkot
GUJARAT
360006
India 
Phone  9764264782  
Fax    
Email  siddhiapatil@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences, Rajkot, Khanderi, Para Pipaliya, Rajkot, Gujarat, INDIA, 360006 
 
Primary Sponsor  
Name  None 
Address  Not Applicable 
Type of Sponsor  Other [None] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Garima Upreti  All India Institute of Medical Sciences-Rajkot  Department of Otorhinolaryngology, All India Institute of Medical Sciences, Rajkot, Gujarat, India
Rajkot
GUJARAT 
9871252109

grmprt@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, AIIMS Rajkot  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H818||Other disorders of vestibular function,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional vestibular rehabilitation therapy (VRT)  Participants allocated to this treatment arm will undergo traditional vestibular rehabilitation therapy, which typically involves a series of exercises based on the principles of habituation, adaptation and substitution designed to promote functional compensation for the vestibular dysfunction. Participants are expected to attend once a week supervised session of 30 minutes duration each. They are expected to continue the same exercises at their home for atleast 30 minutes duration daily, for a total duration of 6 weeks  
Intervention  Virtual Reality Assisted Therapy (VRAT)  Participants allocated to this treatment arm will receive Virtual Reality (VR) assisted therapy in addition to Conventional VRT. VRAT utilizes immersive virtual reality environments to enhance the effectiveness of vestibular rehabilitation. Participants will engage in customized VR exercises designed to challenge and improve their balance, spatial orientation, and vestibular function. The VR system may include interactive tasks, games, or simulations that simulate real-world environments and activities. Duration of each session : 30 to 40 minutes of Virtual reality sessions (thrice a week) in addition to supervised conventional vestibular rehabilitation therapy (30 minutes duration once a week) Frequency of sessions : three sessions per week for a total duration of 6 weeks This is in addition to the conventional VRT (similar to comparator arm) that they are expected to continue practicing for atleast 30 minutes duration daily for 6 weeks.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Chronic vestibular hypofunction:
Duration of vestibular symptoms of 3 months or more
2.Definitive diagnosis of chronic vestibular hypofunction based reduced VOR function documented on one / more of following:
a. VOR gain less than 0.6 on video head impulse test
b. reduced angular VOR gain (less than 0.1) on sinusoidal acceleration on rotary chair testing (0.16Hz), Vmax 50 degrees/second and phase lead more than 68 degrees, time constant less than 5 seconds
c. reduced caloric response, sum of bithermal maximum peak SPV on each side less than 6 degrees/ second, % canal paresis as per Jonkees formula 20% or more 
 
ExclusionCriteria 
Details  1. Use of vestibular suppressants in last 72 hours.
2. Diseases with fluctuating vestibulopathy e.g. Meniere’s Disease
3. Already diagnosed clinical psychiatric conditions/ neurodegenerative/ neuromuscular/
musculoskeletal/ motor disorders/ peripheral neuropathy/ arthropathy in lower
extremities/ uncorrected ocular disorders that will interfere with performance of
rehabilitation exercises
4. Significant medical disorders e.g. severe anaemia, uncontrolled hypertension,
cardiorespiratory disorders, epilepsy, vertebro-basilar insufficiency, cervical spondylosis,
etc. that may be aggravated by exercises.
5. Pregnant females
6. Inability to follow-up  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Patient reported outcome measures: Dizziness Handicap Inventory (DHI), Activities-specific Balance Confidence Scale (ABC), Vestibular Rehabilitation Benefit Questionnaire (VRBQ), Visual Vertigo Analogue Scale (VVAS)

Clinical assessment tools: Berg Balance Scale, Dynamic Gait Index, Timed up and Go (TUG) test

Objective vestibular testing: Video Head Impulse Test, Rotary chair testing, Bithermal Caloric test, Computerized Dynamic Posturography, Craniocorporography
 
1. Baseline assessment (at presentation)

2. At 6 weeks (at completion of intervention)

3. At 12 weeks (6 weeks post completion of intervention)

4. At 18 weeks (12 weeks post completion of intervention)
 
 
Secondary Outcome  
Outcome  TimePoints 
Nil   Nil 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  10/10/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [grmprt@gmail.com].

  6. For how long will this data be available start date provided 01-10-2026 and end date provided 01-10-2029?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

The primary purpose of this study is to evaluate the effectiveness of Virtual Reality Assisted Therapy (VRAT) as an adjunct to Conventional Vestibular Rehabilitation Therapy (VRT) in patients with chronic vestibular hypofunction. The study aims to assess whether the addition of VRAT can enhance treatment outcomes, improve patient compliance, and ultimately lead to a significant improvement in symptoms and quality of life compared to VRT alone. The hypothesis of this study is that the combination of VRAT and VRT will be more effective in reducing symptoms of chronic vestibular hypofunction and improving patient-reported outcomes than VRT alone. Specifically, it is expected that patients receiving both VRAT and VRT will show greater improvements in objective vestibular assessments and patient-reported outcome measures (PROMs) compared to those undergoing conventional VRT alone.

 
Close